Raymond James Financial »

Cytomx Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $937k 294k 3.19
2025-06-30 $644k 284k 2.27

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Tang Capital Management
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Balyasny Asset Management
Baker Bros. Advisors
Point72 Asset Management
ADAR1 Capital Management
Kynam Capital Management
Rtw Investments
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics